European Heart Journal Advance Access published online on July 10, 2006
European Heart Journal, doi:10.1093/eurheartj/ehl137
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institute of Sports Medicine and Science, Italian National Olympic Committee, Via dei Campi Sportivi, 46, 00197 Rome, Italy
* To whom correspondence should be addressed. Aims Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in young athletes, and substantial interest persists in strategies for timely identification. We assessed the diagnostic efficacy of Italian pre-participation screening programme with 12-lead ECG (in addition to history and physical examination) for identification of HCM. Methods and results Four thousand four hundred and fifty members of the Italian national teams, initially judged eligible for competition as a result of systematic pre-participation screening across Italy, subsequently underwent clinical and echocardiographic examination at the Institute of Sports Medicine and Science (Rome) to assess the presence of previously undetected HCM. None of the 4450 athletes showed clinical evidence of HCM. Other cardiac abnormalities were detected in only 12 athletes, including myocarditis (n = 4), mitral valve prolapse (n = 3), Marfan's syndrome (n = 2), aortic regurgitation with bicuspid valve (n = 2), and arrhythmogenic right ventricular cardiomyopathy (n = 1). In addition, echocardiography identified four athletes with borderline left ventricular wall thickness (i.e. 13 mm) in the ‘grey zone’ of overlap between HCM and athlete's heart. In two of these athletes, subsequent genetic analysis or clinical changes over an average 8-year follow-up resulted, respectively, in a definitive or possible diagnosis of HCM. Conclusion The Italian national pre-participation screening programme including 12-lead ECG appears to be efficient in identifying young athletes with HCM, leading to their timely disqualification from competitive sports. These data also suggest that routine echocardiography is not an obligatory component of broad-based screening programmes designed to identify young athletes with HCM.
Received February 3, 2006
Revised May 24, 2006
Accepted June 15, 2006
Clinical research
Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes
Antonio Pelliccia 1 *,
Fernando M. Di Paolo 1,
Domenico Corrado 2,
Cosimo Buccolieri 1,
Filippo M. Quattrini 1,
Cataldo Pisicchio 1,
Antonio Spataro 1,
Alessandro Biffi 1,
Maristella Granata 1,
and
Barry J. Maron 3
2 Department of Cardiology, University of Padua, Padua, Italy
3 The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA
Antonio Pelliccia, E-mail: ant.pelliccia{at}libero.it
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Ostman-Smith, A. Wisten, E. Nylander, E.-L. Bratt, A. de-Wahl Granelli, A. Oulhaj, and E. Ljungstrom Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy Eur. Heart J., November 5, 2009; (2009) ehp443v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Papadakis and S Sharma Electrocardiographic screening in athletes: the time is now for universal screening Br. J. Sports Med., September 1, 2009; 43(9): 663 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Schmied, Y Zerguini, A Junge, P Tscholl, A Pelliccia, B M Mayosi, and J Dvorak Cardiac findings in the precompetition medical assessment of football players participating in the 2009 African Under-17 Championships in Algeria Br. J. Sports Med., September 1, 2009; 43(9): 716 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Bessem, F P Groot, and W Nieuwland The Lausanne recommendations: a Dutch experience Br. J. Sports Med., September 1, 2009; 43(9): 708 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. McLeod, M. J. Ackerman, R. A. Nishimura, A. J. Tajik, B. J. Gersh, and S. R. Ommen Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J. Am. Coll. Cardiol., July 14, 2009; 54(3): 229 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Papadakis, S. Basavarajaiah, J. Rawlins, C. Edwards, J. Makan, S. Firoozi, L. Carby, and S. Sharma Prevalence and significance of T-wave inversions in predominantly Caucasian adolescent athletes Eur. Heart J., July 2, 2009; 30(14): 1728 - 1735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Corrado, C. Basso, A. Pelliccia, and G. Thiene CHAPTER 32 Sports and Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Corrado, C. Basso, M. Schiavon, A. Pelliccia, and G. Thiene Pre-Participation Screening of Young Competitive Athletes for Prevention of Sudden Cardiac Death J. Am. Coll. Cardiol., December 9, 2008; 52(24): 1981 - 1989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pelliccia, D. P. Zipes, and B. J. Maron Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations Revisited: A Comparison of U.S. and European Criteria for Eligibility and Disqualification of Competitive Athletes With Cardiovascular Abnormalities J. Am. Coll. Cardiol., December 9, 2008; 52(24): 1990 - 1996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Papadakis, G. Whyte, and S. Sharma Preparticipation screening for cardiovascular abnormalities in young competitive athletes BMJ, September 29, 2008; 337(sep29_1): a1596 - a1596. [Full Text]
|
|
|
|
|
|
F. Sofi, A. Capalbo, N. Pucci, J. Giuliattini, F. Condino, F. Alessandri, R. Abbate, G. F. Gensini, and S. Califano Cardiovascular evaluation, including resting and exercise electrocardiography, before participation in competitive sports: cross sectional study BMJ, July 3, 2008; 337(jul03_2): a346 - a346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Vetter, J. Elia, C. Erickson, S. Berger, N. Blum, K. Uzark, and C. L. Webb Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Medications for Attention Deficit/Hyperactivity Disorder: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing Circulation, May 6, 2008; 117(18): 2407 - 2423. [Full Text] [PDF]
|
|
|
|
|
|
I. Ostman-Smith, G. Wettrell, B. Keeton, D. Holmgren, U. Ergander, S. Gould, C. Bowker, and M. Verdicchio Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy Eur. Heart J., May 1, 2008; 29(9): 1160 - 1167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Basavarajaiah, M. Wilson, G. Whyte, A. Shah, W. McKenna, and S. Sharma Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J. Am. Coll. Cardiol., March 11, 2008; 51(10): 1033 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pelliccia, F. M. Di Paolo, F. M. Quattrini, C. Basso, F. Culasso, G. Popoli, R. De Luca, A. Spataro, A. Biffi, G. Thiene, et al. Outcomes in Athletes with Marked ECG Repolarization Abnormalities N. Engl. J. Med., January 10, 2008; 358(2): 152 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Myerburg and V. L. Vetter Electrocardiograms Should Be Included in Preparticipation Screening of Athletes Circulation, November 27, 2007; 116(22): 2616 - 2626. [Full Text] [PDF]
|
|
|
|
|
|
A. Pelliccia The preparticipation cardiovascular screening of competitive athletes: is it time to change the customary clinical practice? Eur. Heart J., November 2, 2007; 28(22): 2703 - 2705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Q Osborn, W. C Taylor, K. Oken, M. Luzano, M. Heckman, and G. Fletcher Echocardiographic characterisation of left ventricular geometry of professional male tennis players Br. J. Sports Med., November 1, 2007; 41(11): 789 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kasikcioglu Gray zone problem in athletes Eur. Heart J., October 1, 2007; 28(19): 2415 - 2416. [Full Text] [PDF]
|
|
|
|
|
|
A. Pelliccia, F. Culasso, F. M. Di Paolo, D. Accettura, R. Cantore, W. Castagna, A. Ciacciarelli, G. Costini, B. Cuffari, E. Drago, et al. Prevalence of abnormal electrocardiograms in a large, unselected population undergoing pre-participation cardiovascular screening Eur. Heart J., August 2, 2007; 28(16): 2006 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nistri, I. Olivotto, F. Cecchi, C. Basso, and G. Thiene ECG-based screening: not only for athletes Eur. Heart J., May 1, 2007; 28(9): 1170 - 1170. [Full Text] [PDF]
|
|
|
|
|
|
D. Corrado, A. Pelliccia, H. H. Bjornstad, G. Thiene, and On behalf of the Study Group on Sports Cardiology Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: reply Eur. Heart J., December 1, 2006; 27(23): 2905 - 2906. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Corrado, C. Basso, A. Pavei, P. Michieli, M. Schiavon, and G. Thiene Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program JAMA, October 4, 2006; 296(13): 1593 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Panhuyzen-Goedkoop and F. W.A. Verheugt Sudden cardiac death due to hypertrophic cardiomyopathy can be reduced by pre-participation cardiovascular screening in young athletes Eur. Heart J., September 2, 2006; 27(18): 2152 - 2153. [Full Text] [PDF]
|
|